Related Experiment Videos
Identification of two distinct synucleins from human brain
R Jakes1, M G Spillantini, M Goedert
1MRC Laboratory of Molecular Biology, Cambridge, UK.
FEBS Letters
|May 23, 1994
Summary
Researchers identified two new human brain proteins, alpha-synuclein and beta-synuclein. These proteins are homologous and concentrated in nerve terminals, defining a new synuclein family.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Two abundant proteins, 140 and 134 amino acids long, were purified and sequenced from human brain tissue.
- Identification was achieved using immunoblots with a monoclonal antibody recognizing tau protein in a phosphorylation-dependent manner.
Purpose of the Study:
- To identify and characterize two abundant, novel proteins from human brain.
- To investigate the relationship and homology between these proteins and known synucleins.
Main Methods:
- Protein purification and sequencing from human brain.
- Immunoblot analysis using a phosphorylation-dependent anti-tau monoclonal antibody.
- Sequence homology comparison with known synuclein proteins and bovine phosphoneuroprotein 14.
Main Results:
- The 140 amino acid protein is identical to the precursor of non-A beta component of Alzheimer's disease amyloid, homologous to synuclein.
- The 134 amino acid protein is the human homologue of bovine phosphoneuroprotein 14, sharing 61% sequence identity with the 140 amino acid protein.
- A previously unrecognized homology was found, defining a family of human brain synucleins: alpha-synuclein (140 aa) and beta-synuclein (134 aa).
Conclusions:
- Two distinct human brain synucleins, alpha-synuclein and beta-synuclein, have been identified and characterized.
- These proteins are predominantly expressed in the brain and concentrated in presynaptic nerve terminals.
- The discovery establishes a new family of synuclein proteins in the human brain.